Navigation Links
Varian, Inc. to Release Fourth Quarter and Full Fiscal Year 2009 Financial Results
Date:11/3/2009

PALO ALTO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its fourth quarter and full fiscal year 2009 financial results after 1:00 p.m. Pacific Time (PT) on Wednesday, November 4, 2009. Due to its pending acquisition by Agilent Technologies, Inc., the company will not be holding an investor conference call to review those results.

About Varian, Inc.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science, environmental, energy, and applied research and other applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc.'s common stock is traded on the NASDAQ Global Select Market under the symbol "VARI." Further information is available on the company's Web site at http://www.varianinc.com.

    For More Information, Contact:
    Investor Relations
    Varian, Inc.
    650.424.5471
    ir@varianinc.com

SOURCE Varian, Inc.


'/>"/>
SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
2. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
3. Educational Video Series Released for American Diabetes Month
4. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
5. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
6. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
7. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
8. ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call
9. CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis
10. Escalon(R) Subsidiary Escalon Digital Solutions Announces Release of Web-Based AXIS(TM) Image Management System
11. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ass.andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartW...inginnovatorandprovideroflessinvasive,miniaturized...eatmentofadvancedheartfailure,todayannouncedthatit...nualPiperJaffrayHealthCareConferenceat8:00amESTonW...theNewYorkPalaceHotel,December1-2. ,, Alivewebc...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Endologix,Inc.(Nas...foraorticdisorders,announcedtodaythatithasfiledamo...infringementlawsuitbroughtagainstitinOctober2009by...tCourtinIndianapolis,Indiana. ,, Endologixhasre...esPatentandTrademarkOffice(USPTO)conductsproceedin...
(Date:11/24/2009)...E,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.an...nistration(FDA)hasacceptedforreviewEisai,sNewDrugA...ezilHClextendedrelease)tabletsforthetreatmentofmod...oseformulationcontains23mgofdonepezilHClinanextend...allowsforgradualreleaseofthedrug.TheNDAisbasedonah...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Prolonged Use of Pacifier Linked to Speech Problems 59896 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 2Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 3Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 1Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 2
... aimed at reducing cross contamination ...E, Fla., Oct. 18 Seal Shield Corporation,announce...l products for,infection control. Notably, Seal Sh... Washable Keyboard and Mouse. According to the com...he first ever antibacterial,keyboard and mouse to ...
...ssion, ATRIPLA Would Represent the, First and Only...S Patients in the European ... WHITEHOUSE STATION, N.J., Oct.,18 Bristol-Myers ... (Nasdaq: GILD ) and Merck & Co., Inc. (NYSE: MR...al Products for Human Use,(CHMP) of the European M...
Other Medicine Technology:Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 2Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 2European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 4European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 5European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 6European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 7European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 8European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 9European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 10
(Date:11/26/2009)... the number of Americans living with diabetes will...09 to 44.1 million in 2034. Over the same period, ...om $113 billion to $336 billion, even with no incr...ed at the University of Chicago report in the Dece...hose with diabetes covered by Medicare will rise f...
(Date:11/26/2009)...l when on an emotional rollercoaster, study finds ...- Call it the fear factor meets the jubilant sport...- especially those who root for the winning team -...y contested match and victory was in doubt, produc...on that this Thanksgiving weekend as you,re glued ...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leading ...oday announced the expansion of its services to in...r. Doug Macmillan. , D...leased to announce that Dr. Doug Macmillan, an exp...n additional advanced training seminar. RTDental&...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--Whenmostpeoplehearthea...canalsogivepatientsthehelptheyneed.TMJstandsforthe...ble)contacts/connectswithyourskull(temporalbone). ...ctionarepainwithchewing,clickingorpoppingofthejaw....ncluding:headaches,fatigue,sleepdisturbances,irrit...
(Date:11/25/2009)...RY,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...andsoftwareandCalgaryScientificInc.,aleadingprovid...bversionofAegis(TM)Breast4DAdvancedVisualizationso...lyzero-footprintWebclientbasedmedicalimagingofferi...rmallowsforzero-footprintaccess-requiringnosoftwar...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
... come together on West Coast for a free educationa...eir families, SAN DIEGO, CA, Sept. 15 /PRNewswire...are diagnosed with a primary or metastatic brain t...,Tumor Foundation (NBTF) partnered with BrainLAB a...
...serious underlying health trouble, experts say , ...ile the occasional stomachache isn,t a serious hea...other matter that could signal serious trouble, sa...rring pain; , pain lasting for hours or days; , pa...
...upports angioplasty, but not everyone agrees , ...versy still swirls around how doctors can best tre...na, with some physicians favoring the use of drugs...n (COURAGE), seemed to indicate that drug therapy ...
... The Center of Excellence in Environmental Toxicol...l of Medicine has been awarded $2.3,million over t...of,exposure to cigarette smoke. The grant is part ...s and,environmental health scientists. In this fir...
...Leader of the Global Breast Cancer Movement, Takes...LLAS, Sept. 14 The appointment of Ambassador Nanc...re, the world,s largest breast,cancer organization...ally begin work Monday. A ceremonial swearing in,i...
... BIRMINGHAM, Ala., Sept. 14 /PRNewswire-USNewswire... now offering a specialized,professional liability...ls.,The coverage is being made available through P...,s community,based hospitals with our proven, cost...
Other Medicine News:Health News:National Brain Tumor Foundation Unites with BrainLAB in Support of Patient Education 2Health News:National Brain Tumor Foundation Unites with BrainLAB in Support of Patient Education 3Health News:Doctors Debate Drugs vs. Surgery for Angina 2Health News:Doctors Debate Drugs vs. Surgery for Angina 3Health News:Doctors Debate Drugs vs. Surgery for Angina 4Health News:Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure 2Health News:Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure 3Health News:President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol 2Health News:President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol 3Health News:President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol 4Health News:ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan 2
MBP 200GGenomic Tip
MBP 300E Multi-Channel
LH EIA kit
Luteinizing Hormone (LH) Enzyme Immunoassay Test Kit
Medicine Products: